Form 4: ADC Therapeutics Director Ron Squarer Sells Shares to Cover Tax Obligations

Director Ron Squarer sold 6,995 common shares of ADC Therapeutics SA on June 17, 2024, to cover tax withholding obligations related to the vesting of restricted share units.

Summary

• On June 17, 2024, Ron Squarer, a director of ADC Therapeutics SA, sold 6,995 common shares of the company.
• The sale was executed at a price of $2.89 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
• Following the transaction, Ron Squarer directly owns 80,663 common shares of ADC Therapeutics SA.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be a routine sale of shares to cover tax obligations, with no indication of a change in the director's outlook on the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and directors. This transaction is a routine part of executive compensation and does not necessarily indicate a change in the director's confidence in the company's future prospects.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, but is unlikely to have a significant long-term effect.

Key Dates